Organo Corp. (JP:6368)
:6368
6368 Stock Chart & Stats
¥15140.00
¥170.00(1.97%)
At close: 4:00 PM EST
¥15140.00
¥170.00(1.97%)
Day’s Range― - ―
52-Week Range¥5,220.00 - ¥18,260.00
Previous CloseN/A
Volume316.80K
Average Volume (3M)305.77K
Market Cap
¥732.16B
Enterprise Value¥739.18B
Total Cash (Recent Filing)¥20.57B
Total Debt (Recent Filing)¥28.15B
Price to Earnings (P/E)23.0
Beta1.48
Next Earnings
May 19, 2026EPS Estimate
189.28Next Dividend Ex-DateN/A
Dividend Yield1.43%
Share Statistics
EPS (TTM)140.73
Shares Outstanding46,359,700
10 Day Avg. Volume290,510
30 Day Avg. Volume305,770
Financial Highlights & Ratios
PEG Ratio0.31
Price to Book (P/B)2.42
Price to Sales (P/S)1.79
P/FCF Ratio11.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥15,000.00Price Target Upside-0.92% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)679.12
Revenue Forecast (FY)¥192.22B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthOrgano has shown durable multi-year top-line expansion with a meaningful acceleration in 2025. That sustained revenue growth reflects structural demand for industrial water treatment and diversified sales across equipment, services and chemicals, supporting predictable medium-term capacity utilization and scale benefits.
Margin ExpansionMaterial margin improvement demonstrates improved operating leverage and/or a better business mix. Higher gross and net margins increase cash generation potential and resilience across cycles, enabling reinvestment in product development and service capabilities, and supporting sustainable profitability over the medium term.
Balance Sheet StrengthLow leverage and rising equity capital provide solid financial flexibility for project-led capex and working-capital needs. Combined with recent strong free cash flow, the healthier capitalization reduces refinancing risk and supports strategic investments or shareholder returns without compromising solvency.
Bears Say
Cash Flow VolatilityHistoric swings in operating cash flow signal working-capital and project-timing volatility. Such inconsistency can complicate budgeting for capex, maintenance and dividends, and raises the risk that short-term liquidity needs or project delays could force unexpected financing or slow reinvestment plans.
Growth VolatilityA concentrated acceleration in a single year suggests revenue is lumpy and tied to big projects or timing effects. This increases forecasting uncertainty and the risk of mean reversion, making medium-term revenue planning and capacity allocation less predictable for management and investors.
Leverage SensitivityWhile current leverage is low, prior periods of higher debt show the balance sheet is sensitive to cyclical funding or investment choices. Such swings can reduce optionality in downturns, increase interest and refinancing risk, and constrain strategic responses if new large projects or adverse market conditions arise.
6368 FAQ
What was Organo Corp.’s price range in the past 12 months?
Organo Corp. lowest stock price was ¥5220.00 and its highest was ¥18260.00 in the past 12 months.
What is Organo Corp.’s market cap?
Organo Corp.’s market cap is ¥732.16B.
When is Organo Corp.’s upcoming earnings report date?
Organo Corp.’s upcoming earnings report date is May 19, 2026 which is in 39 days.
How were Organo Corp.’s earnings last quarter?
Organo Corp. released its earnings results on Feb 04, 2026. The company reported ¥140.73 earnings per share for the quarter, missing the consensus estimate of ¥167.06 by -¥26.33.
Is Organo Corp. overvalued?
According to Wall Street analysts Organo Corp.’s price is currently Overvalued.
Does Organo Corp. pay dividends?
Organo Corp. pays a Semiannually dividend of ¥95 which represents an annual dividend yield of 1.43%. See more information on Organo Corp. dividends here
What is Organo Corp.’s EPS estimate?
Organo Corp.’s EPS estimate is 189.28.
How many shares outstanding does Organo Corp. have?
Organo Corp. has 46,359,700 shares outstanding.
What happened to Organo Corp.’s price movement after its last earnings report?
Organo Corp. reported an EPS of ¥140.73 in its last earnings report, missing expectations of ¥167.06. Following the earnings report the stock price went down -1.856%.
Which hedge fund is a major shareholder of Organo Corp.?
Currently, no hedge funds are holding shares in JP:6368
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Organo Corp.
Organo Corporation operates as a water treatment engineering company in Japan and internationally. The company operates through two segments, Water Treatment Engineering Business Unit and Performance Products Business Unit. It offers pure water systems, such as reverse osmosis (RO) systems, regenerative automatic and manual pure water systems, electric regeneration pure water systems, desktop-type pure water systems, cabinet-type pure water systems, electrode ionization high-purity water systems, cartridge water purifiers, and two-stage RO systems; ultrapure water systems, including desktop and cabinet-type ultrapure water systems, and final polishing unit; and other equipment comprising alkaline electrolyzed water production equipment, homogenizers, electro conductivity meters, resistivity meters, and ion exchange filters. The company also provides water, wastewater, and RO water treatment chemicals; industrial filters consisting of micro filter, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon; and commercial water purifiers. In addition, it offers ultrapure and multi-functional water production systems, wastewater treatment systems, valuable resource recovery systems, and organic solvent refining systems for the electronics industry; water supply and sewage treatment facilities; purified water production and supply systems, UF water production and supply systems, and water for injection production and supply systems, as well as pharmaceutical water system consulting services; condensate filter, condensate demineralizer, reactor water cleanup, fuel pool cleanup, makeup water, and waste water treatment systems; and sugar refining systems and equipment. The company was formerly known as Japan Organo Co., Ltd. and changed its name to Organo Corporation in 1966. Organo Corporation was incorporated in 1941 and is headquartered in Tokyo, Japan.
6368 Stock 12 Month Forecast
Average Price Target
¥15,000.00
▼(-0.92% Downside)
Technical Analysis
Kurita Water Industries
―
METAWATER Co
―
Takuma Co
―
Mitsubishi Kakoki Kaisha,Ltd.
―
Hitachi Zosen Corporation
―
Options Prices
Currently, No data available
---